Clinical trial

Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)

NCT00131664

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-09-01

PhasePHASE3

Study timeline

Study start (unknown)2005-09-01Date precision: month

Registry last updated2013-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

AvandametDRUG

Avandia and AmarylDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Canadian Heart Research Centrelead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00131664 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.